IFOSFAMIDE

Trials studying IFOSFAMIDE

• phase2Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)active not recruitingn=543
• phase2Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcomarecruitingn=406
• phase2A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphomarecruitingn=65
• phase2Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO)active not recruitingn=66
• phase1Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcomaactive not recruitingn=6
• phase3A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphomarecruitingn=216
• phase3A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphomarecruitingn=210
• phase1Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphomaactive not recruitingn=29